FindTrial
Sign In

An audit of fluid treatment during surgeries in preplanned surgeries

Retrospective observational trial of intraoperative fluid management practice in elective cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044946
Enrollment
1000
Registered
2022-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Not Applicable: Not Applicable

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients undergoing elective cancer surgery

Exclusion criteria

Exclusion criteria: Patients with blood loss more than 1 litre

Design outcomes

Primary

MeasureTime frame
Intraoperative IV fluid volume in ml / ideal body weight / hr and type of IV fluids used in different types of surgery.Timepoint: 12 hours—

Secondary

MeasureTime frame
1. Intraoperative complications such as need for vasopressor therapy, need for mechanical ventilation at the end of surgery or side effects of colloids.Timepoint: 30 days;2. In hospital complications will include - Anastomotic dehiscence, ICU /RR stay 48 hrs, sepsis, ICU readmission, re surgery or organ dysfunction. Cardiovascular complications will be defined as any haemodynamic abnormality requiring intervention, need for mechanical ventilation, acute kidney injury, Respiratory complications will be defined as need for mechanical ventilation including HFNC or NIV. CNS dysfunction and liver dysfunction will also be notedTimepoint: 30 days—

Countries

India

Contacts

Public ContactKshitija Pimpre

Tata Memorial Hospital, Mumbai

mshetmahajan@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026